Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699943 · ClinicalTrials.gov registry record · NA
Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.
A NA study of Erectile Dysfunction, sponsored by Creative Medical Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03699943: Completed NA study of Erectile Dysfunction, sponsored by Creative Medical Health.
NCT03699943 is a NA study of Erectile Dysfunction that has completed, run by Creative Medical Health. The registered enrollment target is 40 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03699943, a NA study of Erectile Dysfunction, has completed, sponsored by Creative Medical Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assessed the safety and efficacy of autologous bone marrow concentrate and injected intra-cavernously into patients with erectile dysfunction (ED). Specifically, this study will evaluate ED treatment \>18 year old men, a demographic where the etiology of ED is attributable primarily to the loss of corporal smooth muscle in the penis. Study endpoints will evaluate the safety and efficacy of intracavernosal bone marrow concentrate administration for treating ED patients.
Primary Outcome
IIEF-5 scale
Conditions Studied
Interventions
- PROCEDURE CaverStem
Study Locations (1)
California
- Harbor - UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-12-08 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
What the finished NCT03699943 record still lists
NCT03699943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which CaverStem is the first listed.
NCT03699943 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03699943 about?
NCT03699943 is a clinical study titled "Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.". This study assessed the safety and efficacy of autologous bone marrow concentrate and injected intra-cavernously into patients with erectile dysfunction (ED). Specifically, this study will evaluate ED treatment \>18 year old men, a demographic where the etiology of ED is attributable primarily to th...
What is the current status of trial NCT03699943?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-12-08. Estimated completion is 2019-08-31.
What conditions does trial NCT03699943 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT03699943?
The interventions under investigation include: CaverStem (PROCEDURE).
Who is sponsoring clinical trial NCT03699943?
This trial is sponsored by Creative Medical Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03699943 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03699943's enrollment target sits among peer trials
40 22nd of 33 higher than 11 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI